Browse report : http://www.transparencymarketresearch.com/stem-cells-market.html

Therapeutic research activities boosting the stem cells market
There has been growing awareness across regions regarding the importance of stem cells and stem cell banking services, significance of stem cells in drug discovery and development, and regenerative treatment options. This, backed by government support, has triggered a spurt in therapeutic research activities in the field of stem cells, thereby driving the global market. Rising number of patients with neurodegenerative disorders, growing trend of replacing animal tissue in drug discovery, and an expanding contract research industry are potential growth opportunities for the stem cells market. On the other hand, high cost of treatment and government laws regarding unethical harvesting of stem cells is expected to restrain the market.

Stem cells market – A highly fragmented industry
The global stem cells market can be segmented on the basis four main parameters: product, technology, application, and geography. On the basis of products, the stem cell market is divided into adult stem cell, induced pluripotent stem cell, rat neural stem cell, human embryonic stem cell, and very small embryonic-like stem cell. Adult stem cells are further segmented into hematopoietic stem cell, neuronal stem cell, dental stem cell, mesenchymal stem cell, and umbilical cord stem cell. On the basis of application, the stem cells market is broadly categorized as drug discovery and development and regenerative medicines.

Regenerative medicines is further segmented into injuries, neurological disorders, Crohn’s disease, orthopedics, cancer, organ transplants, incontinence, infertility, diabetes, hematological disorders, liver disorders, cardiovascular and myocardial infarction, and immunodeficiency disorders. On the basis of technology, the stem cells market is segmented into stem cell expansion and sub-culture, stem cell cryopreservation, stem cell acquisition, and stem cell production. On the basis of geography, the global stem cells market is divided into North America, Europe, Asia-Pacific, and Rest of the World.

Adult stem cells most flourishing segment
At over 80%, the adult stem cells segment accounted for a majority of the overall stem cells market owing to fewer chances of contamination during stem cell expansion and sub-culture, and fewer hassles while harvesting. However, the induced pluripotent stem cells segment is expected to grow at a relatively faster CAGR due to lesser post-transplant complications and fewer risks of graft-versus-host reaction. Among the major applications, regenerative medicines led the overall stem cells market in 2011 and will continue to dominate the scene owing to significant research and resultant therapies in the field of neurology.

North America heading the global market
The continuous and tremendous support by the government in North America makes it the leader of the global market. Termed as the center of stem cells research, the region has developed over the years due to higher affordability of treatment. The European stem cells market is also gaining prominence due to higher incidences of chronic diseases and research investments from government and private organizations. However, factors such as improving economic stability, rising disposable income, growing medical tourism in emerging countries such as China and India, migration of patients from the U.S. and Europe for cheaper yet quality treatment, flourishing contract research industry, and high rate of chronic diseases is expected to propel the stem cells market in Asia.

Industry leaders

The key players of the global stem cells market include California Stem Cell Inc., Cellular Engineering Technologies, Biotime Inc., Brainstorm Cell Therapeutics, Cytori Therapeutics Inc., Celgene Corporation Inc., Bioheart, Cellartis AB, Osiris Therapeutics, Angel Biotechnology, Advanced Cell Technology, and Stemcelltechnologies Inc.
According to a recent report published by a market intelligence company, the worldwide stem cells market was valued at US$26.23 billion in the year 2013 and is forecast to be worth US$119.52 by 2019, growing at a CAGR of 24.2%.

Request a Sample of this Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=132


About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.